GRCE
Grace Therapeutics, Inc. Common Stock
GRCE
GRCE
33 hedge funds and large institutions have $12.6M invested in Grace Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+6
Holders Change %
+22.22%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
8
Reduced
4
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$1.52M |
2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$676K |
3 |
Renaissance Technologies
New York
|
+$538K |
4 |
Morgan Stanley
New York
|
+$412K |
5 |
Barclays
London,
United Kingdom
|
+$245K |